A Low-fat Diet Combined With Moderate-intensity Aerobic Exercise Versus Low-fat Diet, Aerobic Exercise Alone on Dyslipidemia and Depression Status in Obese Patients
Overview
It was defined that exercise and dietary interventions are used to control dyslipidemia and depression in obese individuals, whilst rare investigations have examined the concurrent effects of a low-fat diet and moderate-intensity aerobic exercise training (MIAET) on dyslipidemia and depression in obese patients. Hence, we assessed the potential influences of a low-fat diet combined with MIAET on blood lipids and depression in those individuals.
Full Title of Study: “A Low-fat Diet Combined With Moderate-intensity Aerobic Exercise is More Effective Than a Low-fat Diet or Aerobic Exercise Alone on Dyslipidemia and Depression Status in Obese Patients”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Single (Investigator)
- Study Primary Completion Date: January 2, 2020
Interventions
- Other: Moderate-intensity aerobic exercise training
- The first group has received Moderate-intensity aerobic exercise training without dietary control, the second group has received a low-fat diet program without exercise intervention, and the third group has received Moderate-intensity aerobic exercise training plus a low-fat diet program for 10 consecutive weeks
Arms, Groups and Cohorts
- Experimental: Moderate-intensity aerobic exercise training without dietary control group
- Experimental: Low-fat diet program without exercise intervention group
- Experimental: Moderate-intensity aerobic exercise training plus a low-fat diet program group
Clinical Trial Outcome Measures
Primary Measures
- Body Mass Index
- Time Frame: 10 weeks
- The height and weight were assessed using an electronic digital scale and consequently BMI was calculated
Participating in This Clinical Trial
Inclusion Criteria
- age of 30-50 years – clinical diagnosis with obesity (BMI˃30) – mild to moderate depression – impaired blood lipids – no use of medications last 6-12 months – no smoking Exclusion Criteria:
- neuromuscular, endocrinal, musculoskeletal, cardiovascular disorders – severe depression – patients using medications of dyslipidemia, depression, or obesity last 6-12 months.
Gender Eligibility: All
Minimum Age: 30 Years
Maximum Age: 50 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Cairo University
- Provider of Information About this Clinical Study
- Principal Investigator: Marwa Eid, assistant professor of physical therapy for surgery – Cairo University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.